ALEMBIC LTD. SHARE PRICE [LIVE]

BSE: INE426A01027   NSE: ALEMBICLTD   SECTOR: Pharma

OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
72.80
Change:
BSE
72.90
Change:
NSE
BSE Click here to view BSE data
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality
Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name Mar 21 Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in ALEMBIC LTD.

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

ALEMBICLTD News

Frequently Asked Questions

What is the Share price of ALEMBIC LTD. (ALEMBICLTD)?

ALEMBIC LTD. (ALEMBICLTD) share price as of August 16, 2022, on NSE is Rs 72.80 (NSE) and Rs 72.90 (BSE) on BSE.

Can I buy ALEMBIC LTD. (ALEMBICLTD) shares?

Yes, You can buy ALEMBIC LTD. (ALEMBICLTD) shares by opening a Demat account with Angel One.

How do I buy ALEMBIC LTD. (ALEMBICLTD) from Angel One?

ALEMBIC LTD. (ALEMBICLTD) share can be brought through the following modes:
  1. Direct investment: You can buy ALEMBIC LTD. (ALEMBICLTD) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to ALEMBIC LTD. (ALEMBICLTD) shares.

In which sector do ALEMBIC LTD. (ALEMBICLTD) belong?

ALEMBIC LTD. (ALEMBICLTD) belongs to Pharma.

About ALEMBICLTD

Today's live share price for ALEMBIC LTD. is NSE: ₹ 72.80, BSE: ₹ 72.90 with a current market capitalization of .

Alembic Ltd is one of the India's most experienced manufactures of bulk drugs and pharmaceuticals formulation in human and animal healthcare. They are the first pharmaceutical company in India to cross 100 years of operations. They are in the business of improving the quality of life and healthcare in over 75 countries around the world. The company is a ISO-9002 and ISO-14001 certified company with manufacturing practices and facilities that conform to WHO-GMP guidelines. They manufacture pharmaceuticals and chemicals, bulk drugs (penicillin and other antibiotics) and formulations. They are having their manufacturing facilities at Vadodara in Gujarat and Solan in Himachal Pradesh. Alembic Ltd was incorporated in the year 1907 with the name Alembic Chemical Works Co Ltd in Vadodara to manufacture tinctures and alcohol. They Started to manufacture cough syrup, vitamins, tonics and sulphur durgs in the year 1940. In the year 1961, they inaugrated the Pencillin Palnt. In the year 1968, they started to manufacture Streptomycin. In the 1971, they manufactured Erythromycin using expertise from Eli Lilly, USA and in the year 1972, they launched Althrocin, a brand of Erythromycin. In the year 1997, Althrocin become top selling brand in India. In the year 2001, they started to manufacture Cephalosporin C. In June 2001, the company formed a wholly owned subsidiary company named Alembic Europe Pvt Ltd in UK. In the year 2005, the company has launched ZERO, a new generation, no calories, Sucralose Based Sugar Substitute which gave entry for the company into the high-growth lifestyle OTC product segment. In May 2005, the generic alliances and API division were merged to form an independent SBU. The company has set up a formulation manufacturing facility at Baddi in Himachal Pradesh with a production capacity 900 million tablets and 600 million liquid oral bottles annually. During the year 2005-06, the company has increased the installed capacity of Tablets & Capsules and Oral Preparation & Ointments by 595 Million Nos and 720 MT respectively. During the year 2005-06, the company acquired API Plant at Karakhadi in Vadodara. In the year 2007, the company acquired the Non-Oncology Business of Dabur Pharma Ltd. Also in the same year, they entered into a licensing agreement for its Novel Drug Delivery Platform for Keppra XR with UCB Belgium. During the year 2007-08, the company acquired the API manufacturing facility of Nirayu Pvt Ltd at Panelav near Vododara.

Read more